𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Delayed hemolysis after intravenous anti-D immune globulin infusion in a patient with idiopathic thrombocytopenic purpura

✍ Scribed by Paul G. Rubinstein; Yi-Hsiang Chen

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
369 KB
Volume
83
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Safety and tolerability of a novel chrom
Safety and tolerability of a novel chromatography-based intravenous immunoglobulin when administered at a high infusion rate in patients with immune thrombocytopenic purpura
✍ James B. Bussel; Kim Hanna πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 153 KB πŸ‘ 1 views

## Abstract Intravenous immunoglobulin (IGIV) therapy is generally considered to be a safe and effective treatment for idiopathic thrombocytopenic purpura (ITP). The usual initial treatment dose is 1–2 g/kg body weight, which results in an extended infusion time, significantly impacting patients' d